![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 3
Zeitschriftenartikel
Sarkozy, Clémentine; Chartier, Loïc; Ribrag, Vincent; Gressin, Remy 
ORCID: https://orcid.org/0000-0002-9188-3501; Geisler, Christian H.; Kluin-Nelemans, Hanneke C.; Thieblemont, Catherine ORCID: https://orcid.org/0000-0002-9941-2448; Morschhauser, Franck ORCID: https://orcid.org/0000-0002-3714-9824; Lemonnier, François ORCID: https://orcid.org/0000-0001-6205-5419; Safar, Violaine; Tessoulin, Benoît ORCID: https://orcid.org/0000-0001-7600-3329; Oberic, Lucie; Damaj, Ghandi ORCID: https://orcid.org/0000-0002-4689-3882; Ghesquières, Hervé; Bouabdallah, Krimo; Casasnovas, René Olivier ORCID: https://orcid.org/0000-0002-1156-8983; Houot, Roch; Klapper, Wolfram ORCID: https://orcid.org/0000-0001-7208-4117; Burroni, Barbara; Pott, Christiane ORCID: https://orcid.org/0009-0005-9260-8340; Delfau-Larue, Marie-Hélène; Macintyre, Elizabeth ORCID: https://orcid.org/0000-0003-0520-0493; Callanan, Mary; Jerkeman, Mats; Unterhalt, Michael; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389; Dreyling, Martin ORCID: https://orcid.org/0000-0002-0358-5249; Le Gouill, Steven; Hermine, Olivier und Cheminant, Morgane ORCID: https://orcid.org/0000-0002-2070-9581
(2025):
Validation of POD24 as a robust early clinical indicator of poor survival in mantle cell lymphoma from 1280 patients on clinical trials, a LYSA study.
In: Blood Cancer Journal, Bd. 15, 78
[PDF, 1MB]
ORCID: https://orcid.org/0000-0002-9188-3501; Geisler, Christian H.; Kluin-Nelemans, Hanneke C.; Thieblemont, Catherine ORCID: https://orcid.org/0000-0002-9941-2448; Morschhauser, Franck ORCID: https://orcid.org/0000-0002-3714-9824; Lemonnier, François ORCID: https://orcid.org/0000-0001-6205-5419; Safar, Violaine; Tessoulin, Benoît ORCID: https://orcid.org/0000-0001-7600-3329; Oberic, Lucie; Damaj, Ghandi ORCID: https://orcid.org/0000-0002-4689-3882; Ghesquières, Hervé; Bouabdallah, Krimo; Casasnovas, René Olivier ORCID: https://orcid.org/0000-0002-1156-8983; Houot, Roch; Klapper, Wolfram ORCID: https://orcid.org/0000-0001-7208-4117; Burroni, Barbara; Pott, Christiane ORCID: https://orcid.org/0009-0005-9260-8340; Delfau-Larue, Marie-Hélène; Macintyre, Elizabeth ORCID: https://orcid.org/0000-0003-0520-0493; Callanan, Mary; Jerkeman, Mats; Unterhalt, Michael; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389; Dreyling, Martin ORCID: https://orcid.org/0000-0002-0358-5249; Le Gouill, Steven; Hermine, Olivier und Cheminant, Morgane ORCID: https://orcid.org/0000-0002-2070-9581
(2025):
Validation of POD24 as a robust early clinical indicator of poor survival in mantle cell lymphoma from 1280 patients on clinical trials, a LYSA study.
In: Blood Cancer Journal, Bd. 15, 78
[PDF, 1MB]
Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389; Delfau-Larue, Marie-Hélène ORCID: https://orcid.org/0000-0002-8010-2343; Macintyre, Elizabeth; Jiang, Linmiao ORCID: https://orcid.org/0000-0002-9009-4236; Stilgenbauer, Stephan; Vehling-Kaiser, Ursula; Salles, Gilles ORCID: https://orcid.org/0000-0002-9541-8666; Thieblemont, Catherine ORCID: https://orcid.org/0000-0002-9941-2448; Tilly, Hervé ORCID: https://orcid.org/0000-0001-7022-5246; Wirths, Stefan ORCID: https://orcid.org/0000-0003-2494-9862; Feugier, Pierre; Hübel, Kai; Schmidt, Christian; Ribrag, Vincent; Kluin-Nelemans, Johanna C. ORCID: https://orcid.org/0000-0003-2617-9427; Dreyling, Martin ORCID: https://orcid.org/0000-0002-0358-5249 und Pott, Christiane ORCID: https://orcid.org/0009-0005-9260-8340
(2023):
Predictive Value of Minimal Residual Disease for Efficacy of Rituximab Maintenance in Mantle Cell Lymphoma. Results From the European Mantle Cell Lymphoma Elderly Trial.
In: Journal of Clinical Oncology, Bd. 42, Nr. 5: S. 538-549
ORCID: https://orcid.org/0000-0002-0749-1389; Delfau-Larue, Marie-Hélène ORCID: https://orcid.org/0000-0002-8010-2343; Macintyre, Elizabeth; Jiang, Linmiao ORCID: https://orcid.org/0000-0002-9009-4236; Stilgenbauer, Stephan; Vehling-Kaiser, Ursula; Salles, Gilles ORCID: https://orcid.org/0000-0002-9541-8666; Thieblemont, Catherine ORCID: https://orcid.org/0000-0002-9941-2448; Tilly, Hervé ORCID: https://orcid.org/0000-0001-7022-5246; Wirths, Stefan ORCID: https://orcid.org/0000-0003-2494-9862; Feugier, Pierre; Hübel, Kai; Schmidt, Christian; Ribrag, Vincent; Kluin-Nelemans, Johanna C. ORCID: https://orcid.org/0000-0003-2617-9427; Dreyling, Martin ORCID: https://orcid.org/0000-0002-0358-5249 und Pott, Christiane ORCID: https://orcid.org/0009-0005-9260-8340
(2023):
Predictive Value of Minimal Residual Disease for Efficacy of Rituximab Maintenance in Mantle Cell Lymphoma. Results From the European Mantle Cell Lymphoma Elderly Trial.
In: Journal of Clinical Oncology, Bd. 42, Nr. 5: S. 538-549
Aukema, Sietse M.; Hoster, Eva; Rosenwald, Andreas; Canoni, Danielle; Delfau-Larue, Marie-Hélène; Rymkiewicz, Grzegorz; Thorns, Christoph; Hartmann, Sylvia; Kluin-Nelemans, Hanneke; Hermine, Olivier; Dreyling, Martin und Klapper, Wolfram
(Januar 2018):
Expression of TP53 is associated with outcome of MCL independent of MIPI and Ki-67 in trials of the European-MCL Network.
In: Blood, Bd. 131, Nr. 4: S. 417-20